Retreatment of Patients With Refractory Large B Cell Lymphoma With Axicabtagene Ciloleucel (Axi-Cel) in ZUMA-1

被引：0

作者：

Locke, Frederick ^{[1
]}

Bartlett, Nancy ^{[2
,3
]}

Jacobson, Caron ^{[4
]}

Oluwole, Olalekan ^{[5
]}

Munoz, Javier ^{[6
]}

Lekakis, Lazaros ^{[7
]}

Topp, Max ^{[8
]}

Avivi, Irit ^{[9
]}

Kim, Jenny ^{[10
]}

Chu, Rong ^{[10
]}

Zheng, Lianqing ^{[10
]}

Rossi, John ^{[10
]}

Bot, Adrian ^{[10
]}

Neelapu, Sattva ^{[11
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Washington Univ, Sch Med, St Louis, MO 14263 USA

[3] Washington Univ, Siteman Canc Ctr, St Louis, MO 14263 USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[6] Banner MD Anderson Canc Ctr, Gilbert, AZ USA

[7] Univ Miami Hlth Syst, Sylvester Comprehens Canc Ctr, Miami, FL USA

[8] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[9] Sourasky Med Ctr, Tel Aviv, Israel

[10] Kite, Santa Monica, CA USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2020年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-25

引用

页码：S21 / S22

页数：2

共 50 条

[31] Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)
Topp, Max S.
van Meerten, Tom
Houot, Roch
Minnema, Monique
Milpied, Noel
Lugtenburg, Pieternella J.
Thieblemont, Catherine
Wermke, Martin
Song, Kevin
Avivi, Irit
Kuruvilla, John
Duehrsen, Ulrich
Chu, Rachel
Zheng, Lianqing
Plaks, Vicki
Kerber, Anne
Kersten, Marie Jose
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S101 - S101
[32] Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)
Topp, Max S.
van Meerten, Tom
Hout, Roch
Minnema, Monique C.
Milpied, Noel
Lugtenburg, Pieternella J.
Thieblemont, Catherine
Wermke, Martin
Song, Kevin W.
Avivi, Irit
Kuruvilla, John
Duehrsen, Ulrich
Chu, Rong
Zheng, Lianqing
Plaks, Vicki
Kerber, Anne
Kersten, Marie Jose
MOLECULAR THERAPY, 2020, 28 (04) : 577 - 577
[33] Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel)
Jacobson, Caron
Locke, Frederick L.
Ghobadi, Armin
Miklos, David B.
Lekakis, Lazaros J.
Oluwole, Olalekan O.
Lin, Yi
Braunschweig, Ira
Hill, Brian T.
Timmerman, John M.
Deol, Abhinav
Reagan, Patrick M.
Stiff, Patrick J.
Flinn, Ian W.
Farooq, Umar
Goy, Andre H.
McSweeney, Peter A.
Munoz, Javier
Siddiqi, Tanya
Rossi, John M.
Bot, Adrian
Zheng, Lianqing
Vezan, Remus
Bashir, Zahid
Kim, Jenny J.
Chu, Rong
Neelapu, Sattva S.
BLOOD, 2020, 136
[34] A standardized comparison of outcomes in patients (pts) with refractory, aggressive non-hodgkin Lymphoma (rNHL) from the SCHOLAR-1 analysis and the ZUMA-1 study of axicabtagene ciloleucel (axi-cel)
Neelapu, S. S.
Locke, F. L.
Bartlett, N. L.
Lekakis, L. J.
Reagan, P. M.
Miklos, D.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O.
Siddiqi, T.
Lin, Y.
Crump, M.
Kuruvilla, J.
Van den Neste, E.
Link, B. K.
Farooq, U.
Navale, L.
Go, W. Y.
Wiezorek, J.
Gisselbrecht, C.
ANNALS OF ONCOLOGY, 2017, 28
[35] Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6
Oluwole, Olalekan O.
Forcade, Edouard
Munoz, Javier
de Guibert, Sophie
Vose, Julie M.
Bartlett, Nancy L.
Lin, Yi
Deol, Abhinav
McSweeney, Peter A.
Goy, Andre H.
Kersten, Marie Jose
Jacobson, Caron A.
Farooq, Umar
Minnema, Monique C.
Thieblemont, Catherine
Timmerman, John
Stiff, Patrick
Avivi, Irit
Tzachanis, Dimitrios
Zheng, Yan
Vardhanabhuti, Saran
Nater, Jenny
Shen, Rhine R.
Miao, Harry
Kim, Jenny
van Meerten, Tom
BLOOD, 2022, 140 : 10399 - 10401
[36] Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory diffuse large B cell lymphoma (DLBCL)
Jacobson, Caron A.
Westin, Jason R.
Miklos, David B.
Herrera, Alex F.
Lee, Jennifer
Seng, Judy
Rossi, John M.
Sun, Jennifer
Dong, Jinghui
Roberts, Zachary J.
Vezan, Remus
Avanzi, Mauro P.
Locke, Frederick L.
CANCER RESEARCH, 2020, 80 (16)
[37] ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)
Kenderian, Saad S.
Oluwole, Olalekan O.
McCarthy, Philip L.
Reshef, Ran
Shiraz, Parveen
Ahmed, Omar
Le Gall, John
Nahas, Myrna
Tang, Lily
Neelapu, Sattva S.
BLOOD, 2020, 136
[38] Durability of Response in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel in the Pivotal Phase 2 Study, ZUMA-1
Locke, Frederick L.
Ghobadi, Armin
Jacobson, Caron A.
Jacobsen, Eric
Miklos, David B.
Lekakis, Lazaros J.
Braunschweig, Ira
Oluwole, Olalekan O.
Lin, Yi
Siddiqi, Tanya
Deol, Abhinav
Reagan, Patrick M.
Farooq, Umar
Bot, Adrian
Jiang, Yizhou
Rossi, John M.
Xue, Allen
Go, William Y.
Neelapu, Sattva S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S277 - S278
[39] The Phase 3, Randomized Study of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma: ZUMA-7
Schmitz, N.
Oluwole, O. O.
Bishop, M. R.
Gisselbrecht, C.
Gordon, L. I.
Kersten, M. J.
Maloney, D. G.
Caballero, M. D.
Kuruvilla, J.
Song, K. W.
Jacobson, C. A.
Nastoupil, L. J.
Riedell, P.
Jiang, Y.
Rossi, J. M.
Lee, L.
Cheng, P.
Locke, F. L.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 90 - 91
[40] CLINICAL AND BIOLOGIC COVARIATES OF OUTCOMES IN ZUMA-1: A PIVOTAL TRIAL OF AXICABTAGENE CILOLEUCEL (AXI-CEL; KTE-C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON-HODGKIN LYMPHOMA (NHL)
Locke, F. L.
Neelapu, S. S.
Bartlett, N. L.
Lekakis, L. J.
Miklos, D.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O.
Siddiqi, T.
Lin, Y.
Timmerman, J.
Reagan, P. M.
Bot, A.
Rossi, J.
Navale, L.
Jiang, Y.
Aycock, J.
Elias, M.
Wiezorek, J.
Go, W. Y.
HAEMATOLOGICA, 2017, 102 : 172 - 172

← 1 2 3 4 5 →